Engineering IgG-like ACE2 antivirals against future pathogenic coronavirus events

Read full text
Authors: Therapeutic Innovation Australia
Cited by: 0

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research Monoclonal and Polyclonal Antibodies Research Animal Virus Infections Studies

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN